Dose proportionality and BE [Design Issues]

posted by sciguy – Canada, 2011-11-02 17:52 (4979 d 10:00 ago) – Posting: # 7586
Views: 9,255

Hi all,

I'm new to the forum and just wanted to get opinions from the group on the following issue:
The sponsor wants to compare two different formulations of a drug with 2 different strengths, say 5 mg vs 10 mg. Dose normalization on the relevant PK parameters is performed and the assessment of equivalence using standard BE criteria is applied. If BE is met, we can only conclude dose proportionality but not bioequivalence since 2 different strengths are being compared. True bioequivalence must be evaluated on non dose-normalized data. Agree/disagree?

Thanks a lot!

sciguy

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
47 visitors (0 registered, 47 guests [including 14 identified bots]).
Forum time: 04:52 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5